Does Blue Cross Blue Shield Cover Sublocade? Prior Authorization and Denials

Most Blue Cross Blue Shield plans do cover Sublocade, the once-monthly buprenorphine injection for moderate to severe opioid use disorder, but almost always with prior authorization and sometimes with step therapy or outright exclusions. Whether Blue Cross Blue Shield covers Sublocade for you specifically depends on which BCBS company administers your plan, whether it’s commercial, Medicaid, Medicare Advantage, or federal, and the state you live in. With a wholesale acquisition cost around $2,202 per monthly dose, those details carry real financial weight.1Sublocade. WAC Pricing Disclosure

Why Coverage Varies So Much Across BCBS Plans

Blue Cross Blue Shield isn’t one insurer. It’s a federation of more than 30 independent companies, and each sets its own formulary, prior authorization rules, and medical policies. A BCBS member in Louisiana can have very different Sublocade coverage than a member in Mississippi or North Carolina.

Several state plans publish policies that explicitly cover Sublocade when medical necessity criteria are met. BCBS of Louisiana covers it at “parity status” alongside Brixadi, the other extended-release buprenorphine injection, when the member’s contract includes the benefit.2Louisiana Blue Cross Blue Shield. Select Substance Abuse Medications Policy No. 00910 Horizon BCBS of New Jersey considers Sublocade medically necessary for patients who meet detailed clinical criteria.3Horizon BCBSNJ. Buprenorphine Extended-Release Injection Medical Policy 145 BlueCross BlueShield of South Carolina approves it when specific diagnostic, treatment, and safety conditions are satisfied.4BlueCross BlueShield of South Carolina. Extended-Release Injectable Sublocade Medical Policy BCBS of Massachusetts lists Sublocade as a covered Tier 2 pharmacy benefit medication.5Blue Cross Blue Shield of Massachusetts. Sublocade Medication Detail

Not every BCBS plan does. Blue Cross & Blue Shield of Mississippi classifies Sublocade as “not medically necessary” across its standard formularies, pointing to other formulary alternatives; members on the Mississippi State Health Plan have to check separately through their pharmacy benefit manager.6Blue Cross Blue Shield of Mississippi. Buprenorphine Policy L.5.01.475 Healthy Blue, the BCBS-affiliated Medicaid plan in North Carolina, lists Sublocade as a non-preferred product, so patients must try and fail two preferred medications first.7Healthy Blue NC. MAT for Opioid Use Disorder Hot Tip

The practical move is to pull your own plan’s medical policy or drug formulary — not a sibling BCBS plan from another state — before counting on coverage.

Is Sublocade Covered Under Your Medical or Pharmacy Benefit?

Because Sublocade has to be prepared and administered by a healthcare provider and can’t be dispensed to patients, many plans bill it under the medical benefit through the provider’s office. Horizon BCBS of New Jersey handles it that way and lists HCPCS billing codes (J0570, Q9991, Q9992) for provider claims.3Horizon BCBSNJ. Buprenorphine Extended-Release Injection Medical Policy 145

Other plans route it through the pharmacy benefit but require a specialty pharmacy. BCBS of Massachusetts covers Sublocade under the pharmacy benefit and requires purchase through a network specialty pharmacy; mail order isn’t allowed.5Blue Cross Blue Shield of Massachusetts. Sublocade Medication Detail Which category applies changes your cost-sharing, because copays, coinsurance, and deductibles are often different for a medical service than for a pharmacy transaction. Ask your plan directly which benefit processes the claim.

What Prior Authorization Usually Requires

Nearly every BCBS plan that covers Sublocade requires prior authorization before the first injection. The clinical criteria generally track the FDA label, with plans layering on their own conditions.

Across the BCBS plans that have published their rules, common requirements include:

Horizon BCBS of New Jersey adds a urine drug screen confirming abstinence from illicit drugs, and excludes patients with a concurrent moderate or severe alcohol use disorder diagnosis.3Horizon BCBSNJ. Buprenorphine Extended-Release Injection Medical Policy 145

The 2025 Rapid Initiation Change

In February 2025, the FDA approved a label change allowing a rapid initiation path for Sublocade. Instead of seven or more days of oral buprenorphine stabilization, a provider can give a single transmucosal buprenorphine test dose, observe the patient for one hour, and administer the first Sublocade injection the same day.9Indivior. Indivior Announces FDA Approval of Label Changes for Sublocade Injection BCBS of Louisiana’s 2026 policy reflects the updated language, requiring only “a single dose of a transmucosal buprenorphine product” before the injection.2Louisiana Blue Cross Blue Shield. Select Substance Abuse Medications Policy No. 00910 Not all BCBS plans have updated. If your plan’s criteria still reference the seven-day stabilization period, your prescriber may need to raise the new labeling during the prior authorization request.

What You’ll Actually Pay

Costs break down by plan type.

On commercial BCBS plans, the manufacturer’s INSUPPORT copay assistance card can eliminate most or all of the drug cost. According to Indivior, 95% of enrolled privately insured patients pay nothing for the medication. The card covers up to $2,202.03 per injection for the first two injections each calendar year and up to $800 per injection for the rest, with an annual cap of $14,804.06 across a maximum of 15 injections.10INSUPPORT. Copay Assistance Terms and Conditions It covers the drug only, not office visits or administration fees.

Patients on government-funded coverage, including Medicare, Medicaid, VA, and TRICARE, aren’t eligible for the manufacturer copay card.11INSUPPORT. Copay Assistance Brochure

On BCBS Medicare Advantage, out-of-pocket amounts vary widely. Manufacturer data shows Medicare patients paying anywhere from near zero to more than $1,600 per dose, with an average around $97.12Sublocade. Sublocade Savings and Support Medicare Part B covers FDA-approved buprenorphine formulations, including injectables, when administered through a certified Opioid Treatment Program.13CMS. Opioid Treatment Program Because no national or local coverage determination specifically addresses Sublocade, BCBS Medicare Advantage plans tend to apply their own medical policies — Horizon’s Medicare Advantage members, for instance, follow the plan’s standard Sublocade policy,3Horizon BCBSNJ. Buprenorphine Extended-Release Injection Medical Policy 145 and BCBS of Louisiana’s Medicare Advantage policy also covers it under medical necessity criteria.14Louisiana Blue Cross Blue Shield Providers. Select Substance Abuse Medications Policy No. 086

On BCBS Medicaid managed care plans, costs are usually minimal. Manufacturer data indicates about 90% of Medicaid patients pay nothing out of pocket, with most of the rest paying between one and four dollars per month.12Sublocade. Sublocade Savings and Support Anthem BCBS Healthcare Solutions covers Sublocade for Nevada Medicaid members with prior authorization,15Anthem BCBS. Prior Authorization Requirements for Sublocade while Healthy Blue in North Carolina requires two preferred-drug failures first.7Healthy Blue NC. MAT for Opioid Use Disorder Hot Tip

If you’re on the BCBS Federal Employee Program, Sublocade isn’t listed on the 2026 abbreviated formulary, but that list only shows the most commonly prescribed drugs, so absence doesn’t equal exclusion. FEP members can confirm coverage for the Standard, Basic, or Focus option using the online Prescription Drug Cost Tool or by calling 1-800-624-5060.16FEP Blue. FEP Abbreviated Formulary

Uninsured patients face the full list price of $2,202.03 per month. INSUPPORT at 1-844-467-7778 can help identify other assistance options.12Sublocade. Sublocade Savings and Support

What To Do if BCBS Denies Sublocade

Denials happen for predictable reasons: insufficient documentation of medical necessity, prior authorization not obtained before treatment, no documented opioid use disorder diagnosis, or step therapy not completed. None of these are necessarily final.

The appeal path has three stages.

File an internal appeal within the window stated in your denial notice, usually 60 to 180 days depending on state and plan type. Include a letter of medical necessity from the prescribing clinician along with supporting clinical records. BCBS plans generally must respond within 30 days for standard appeals and 72 hours for urgent cases.17Blue Cross Blue Shield of Illinois. Appeals and Grievances

Ask the treating clinician to request a peer-to-peer review with the plan’s medical reviewer. When the denial is based on medical necessity, this call often resolves it without a formal written appeal.

Request an external independent review if internal appeals are exhausted. A third-party reviewer not employed by the insurer makes a binding decision, and it’s free to the member.

There’s also a parity angle. The Mental Health Parity and Addiction Equity Act requires that if a plan covers substance use disorder benefits, it cannot impose prior authorization, step therapy, or other limitations more restrictive than those applied to medical and surgical benefits.18CMS. Mental Health Parity and Addiction Equity19U.S. Department of Labor. Mental Health and Substance Use Disorder Parity If you believe your denial applies tougher standards to addiction treatment than to comparable medical care, parity complaints go to the state department of insurance for individual and family plans, or to the U.S. Department of Labor for employer-sponsored plans.

A Caveat Even When Coverage Is Approved

Sublocade is distributed under a Risk Evaluation and Mitigation Strategy, a safety program the FDA requires because the drug can cause serious harm or death if injected intravenously. Only certified healthcare settings and specialty pharmacies can order and dispense it, a provider must administer it, and it can never be handed to a patient to take home.20FDA. Sublocade REMS Program Retail pharmacies aren’t currently permitted to certify under REMS.21Indian Health Service. Sublocade REMS Tip Sheet

So even with BCBS approval in hand, you may still need to locate a nearby certified provider. The specialty pharmacy locator on Sublocade’s provider site and the INSUPPORT line can help identify administration sites in your area.22Sublocade HCP. Sublocade Practice Resources It’s worth checking before scheduling your first injection, so an approval doesn’t go to waste on a logistical gap.